Loss of deep cerebellar nuclei neurons in the 3xTg-AD mice and protection by an anti-amyloid β antibody fragment

mAbs

Volumn 5, Issue 5, 2013, Pages 660-664

  Esquerda Canals, Gisela ^a,b   Marti, Joaquim ^b   Rivera Hernández, Geovanny ^a   Giménez Llort, Lydia ^c   Villegas, Sandra ^a  

^a Protein Folding and Stability Group   (Spain)

^b Fisiol y Inmunologia U Fisiol A   (Spain)

^c INSTITUT DE NEUROCIÈNCIES   (Spain)

Author keywords

Alzheimer disease; Cerebellum; DCN neurons; Immunotherapy; ScFv h3D6

Indexed keywords

AMYLOID BETA PROTEIN; SCFV H3D6; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN NERVE CELL; CEREBELLUM NUCLEUS; DENTATE NUCLEUS; FASTIGIAL NUCLEUS; INTERPOSITUS NUCLEUS; MOUSE; NEUROPROTECTION; NONHUMAN;

ALZHEIMER DISEASE; CEREBELLUM; DCN NEURONS; IMMUNOTHERAPY; SCFV-H3D6;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CELL COUNT; CELL SURVIVAL; CEREBELLAR NUCLEI; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MICE; MICE, TRANSGENIC; MUTATION; NEURONS; PRESENILIN-1; SINGLE-CHAIN ANTIBODIES; TAU PROTEINS;

EID: 84883867071     PISSN: 19420862     EISSN: 19420870     Source Type: Journal    
DOI: 10.4161/mabs.25428     Document Type: Article

References (26)

1. World Health Organization, Alzheimer's Disease International. Dementia: A public health Priority. 2012. http://apps.who.int/iris/bitstre am/10665/75263/1/9789241564458-eng.pdf
2. Selkoe DJ. Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J Alzheimers Dis 2001; 3:75-80; PMID:12214075
3. Li YT, Woodruff-Pak DS, Trojanowski JQ. Amyloid plaques in cerebellar cortex and the integrity of Purkinje cell dendrites. Neurobiol Aging 1994; 15:1-9; PMID:8159255; http://dx.doi.org/10.1016/0197-4580(94)90139-2
4. Selkoe DJ. Normal and abnormal biology of the beta-amyloid precursor protein. Annu Rev Neurosci 1994; 17:489-517; PMID:8210185; http://dx.doi. org/10.1146/annurev.ne.17.030194.002421
5. Thal DR, Rüb U, Orantes M, Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 2002; 58:1791-800; PMID:12084879; http://dx.doi.org/10.1212/WNL.58.12.1791
6. Fukutani Y, Cairns NJ, Rossor MN, Lantos PL. Cerebellar pathology in sporadic and familial Alzheimer's disease including APP 717 (Val→Ile) mutation cases: a morphometric investigation. J Neurol Sci 1997; 149:177-84; PMID:9171327; http://dx.doi. org/10.1016/S0022-510X(97)05399-9
7. Lemere CA, Lopera F, Kosik KS, Lendon CL, Ossa J, Saido TC, et al. The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology. Nat Med 1996; 2:1146-50; PMID:8837617; http://dx.doi.org/10.1038/nm1096-1146
8. Giaccone G, Morbin M, Moda F, Botta M, Mazzoleni G, Uggetti A, et al. Neuropathology of the recessive A673V APP mutation: Alzheimer disease with distinctive features. Acta Neuropathol 2010; 120:803-12; PMID:20842367; http://dx.doi.org/10.1007/s00401-010-0747-1
9. Sepulveda-Falla D, Matschke J, Bernreuther C, Hagel C, Puig B, Villegas A, et al. Deposition of hyperphosphorylated tau in cerebellum of PS1 E280A Alzheimer's disease. Brain Pathol 2011; 21:452-63; PMID:21159009; http://dx.doi.org/10.1111/j.1750-3639.2010.00469.x
10. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003; 39:409-21; PMID:12895417; http://dx.doi. org/10.1016/S0896-6273(03)00434-3
11. Clinton LK, Billings LM, Green KN, Caccamo A, Ngo J, Oddo S, et al. Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice. Neurobiol Dis 2007; 28:76-82; PMID:17659878; http://dx.doi.org/10.1016/j. nbd.2007.06.013
12. Mastrangelo MA, Bowers WJ. Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer's disease-related pathologies in male triple-transgenic mice. BMC Neurosci 2008; 9:81; PMID:18700006; http://dx.doi.org/10.1186/1471-2202-9-81
13. Alzheimer's Disease International. World Alzheimer Report 2011: The benefits of early diagnosis and intervention. 2011. www.alz.co.uk/research/ WorldAlzheimerReport2011.pdf
14. Carroll JC, Rosario ER, Kreimer S, Villamagna A, Gentzschein E, Stanczyk FZ, et al. Sex differences in β-amyloid accumulation in 3xTg-AD mice: role of neonatal sex steroid hormone exposure. Brain Res 2010; 1366:233-45; PMID:20934413; http://dx.doi. org/10.1016/j.brainres.2010.10.009
15. Giménez-Llort L, Rivera-Hernández G, Marín-Argany M, Sánchez-Quesada JL, Villegas S. Early intervention in the 3xTg-AD mice with an amyloid β-antibody fragment ameliorates first hallmarks of Alzheimer disease. MAbs 2013; 5:665-77
16. Marín-Argany M, Rivera-Hernández G, Martí J, Villegas S. An anti-Aβ (amyloid β) single-chain variable fragment prevents amyloid fibril formation and cytotoxicity by withdrawing Aβ oligomers from the amyloid pathway. Biochem J 2011; 437:25-34; PMID:21501114; http://dx.doi.org/10.1042/BJ20101712
17. Panza F, Frisardi V, Imbimbo BP, Seripa D, Paris F, Santamato A, et al. Anti-β-amyloid immunotherapy for Alzheimer's disease: focus on bapineuzumab. Curr Alzheimer Res 2011; 8:808-17; PMID:21592055; http://dx.doi.org/10.2174/156720511798192718
18. Panza F, Frisardi V, Solfrizzi V, Imbimbo BP, Logroscino G, Santamato A, et al. Immunotherapy for Alzheimer's disease: From anti-beta-amyloid to tau-based immunization strategies. Immunotherapy 2012
19. Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging 2003; 24:1063-70; PMID:14643377; http://dx.doi.org/10.1016/j. neurobiolaging.2003.08.012
20. Lomoio S, López-González I, Aso E, Carmona M, Torrejón-Escribano B, Scherini E, et al. Cerebellar amyloid-β plaques: disturbed cortical circuitry in AβPP/PS1 transgenic mice as a model of familial Alzheimer's disease. J Alzheimers Dis 2012; 31:285-300; PMID:22561329
21. Heath RG, Harper JW. Ascending projections of the cerebellar fastigial nucleus to the hippocampus, amygdala, and other temporal lobe sites: evoked potential and histological studies in monkeys and cats. Exp Neurol 1974; 45:268-87; PMID:4422320; http://dx.doi.org/10.1016/0014-4886(74)90118-6
22. Delgado-García JM. Structure and function of the cerebellu]. Rev Neurol 2001; 33:635-42; PMID:11784952
23. Cattepoel S, Hanenberg M, Kulic L, Nitsch RM. Chronic intranasal treatment with an anti-Aβ(30-42) scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer's disease. PLoS One 2011; 6:e18296; PMID:21483675; http://dx.doi. org/10.1371/journal.pone.0018296
24. Rivera-Hernández G, Marín-Argany M, Blasco-Moreno B, Bonet J, Oliva B, Villegas S. Elongation of the C-terminal domain of an anti-amyloid β singlechain variable fragment increases its thermodynamic stability and decreases its aggregation tendency. MAbs 2013; 5:678-89
25. Giménez-Llort L, Blázquez G, Cañete T, Rosa R, Vivó M, Oddo S, et al. Modeling neuropsychiatric symptoms of Alzheimer's disease dementia in 3xTg-AD mice. In: Alzheimer's Disease: New Advances. Iqbal K, Winblad B, Avila J, eds. Pianoro (BO), Italy: Medimond SRL, eds., 2006:513-16
26. Martí J, Santa-Cruz MC, Serra R, Valero O, Molina V, Hervás JP, et al. Principal component and cluster analysis of morphological variables reveals multiple discrete sub-phenotypes in weaver mouse mutants. Cerebellum 2013; 12:406-17; PMID:23179325; http://dx.doi. org/10.1007/s12311-012-0429-8